210 related articles for article (PubMed ID: 18633634)
21. Gene expression profiling of idiopathic interstitial pneumonias (IIPs): identification of potential diagnostic markers and therapeutic targets.
Horimasu Y; Ishikawa N; Taniwaki M; Yamaguchi K; Hamai K; Iwamoto H; Ohshimo S; Hamada H; Hattori N; Okada M; Arihiro K; Ohtsuki Y; Kohno N
BMC Med Genet; 2017 Aug; 18(1):88. PubMed ID: 28821283
[TBL] [Abstract][Full Text] [Related]
22. Plasminogen activator inhibitor-1 suppresses profibrotic responses in fibroblasts from fibrotic lungs.
Marudamuthu AS; Shetty SK; Bhandary YP; Karandashova S; Thompson M; Sathish V; Florova G; Hogan TB; Pabelick CM; Prakash YS; Tsukasaki Y; Fu J; Ikebe M; Idell S; Shetty S
J Biol Chem; 2015 Apr; 290(15):9428-41. PubMed ID: 25648892
[TBL] [Abstract][Full Text] [Related]
23. Toll-like receptor 4 activation attenuates profibrotic response in control lung fibroblasts but not in fibroblasts from patients with IPF.
Ebener S; Barnowski S; Wotzkow C; Marti TM; Lopez-Rodriguez E; Crestani B; Blank F; Schmid RA; Geiser T; Funke M
Am J Physiol Lung Cell Mol Physiol; 2017 Jan; 312(1):L42-L55. PubMed ID: 27815256
[TBL] [Abstract][Full Text] [Related]
24. Approaches to evaluation of fibrogenic pathways in surgical lung biopsy specimens.
Hogaboam CM; Carpenter KJ; Evanoff H; Kunkel SL
Methods Mol Med; 2005; 117():209-21. PubMed ID: 16118454
[TBL] [Abstract][Full Text] [Related]
25. GPRC5A reduction contributes to pollutant benzo[a]pyrene injury via aggravating murine fibrosis, leading to poor prognosis of IIP patients.
Huang Z; Wang S; Liu Y; Fan L; Zeng Y; Han H; Zhang H; Yu X; Zhang Y; Huang D; Wu Y; Jiang W; Zhu P; Zhu X; Yi X
Sci Total Environ; 2020 Oct; 739():139923. PubMed ID: 32758941
[TBL] [Abstract][Full Text] [Related]
26. Heterogeneity of incidence and outcome of acute exacerbation in idiopathic interstitial pneumonia.
Arai T; Kagawa T; Sasaki Y; Sugawara R; Sugimoto C; Tachibana K; Kitaichi M; Akira M; Hayashi S; Inoue Y
Respirology; 2016 Nov; 21(8):1431-1437. PubMed ID: 27460223
[TBL] [Abstract][Full Text] [Related]
27. CpG oligonucleotide activates Toll-like receptor 9 and causes lung inflammation in vivo.
Knuefermann P; Baumgarten G; Koch A; Schwederski M; Velten M; Ehrentraut H; Mersmann J; Meyer R; Hoeft A; Zacharowski K; Grohé C
Respir Res; 2007 Oct; 8(1):72. PubMed ID: 17925007
[TBL] [Abstract][Full Text] [Related]
28. POINT: Does Interstitial Pneumonia With Autoimmune Features Represent a Distinct Class of Patients With Idiopathic Interstitial Pneumonia? Yes.
Lee JS; Fischer A
Chest; 2019 Feb; 155(2):258-260. PubMed ID: 30732687
[No Abstract] [Full Text] [Related]
29. Profibrotic effect of IL-17A and elevated IL-17RA in idiopathic pulmonary fibrosis and rheumatoid arthritis-associated lung disease support a direct role for IL-17A/IL-17RA in human fibrotic interstitial lung disease.
Zhang J; Wang D; Wang L; Wang S; Roden AC; Zhao H; Li X; Prakash YS; Matteson EL; Tschumperlin DJ; Vassallo R
Am J Physiol Lung Cell Mol Physiol; 2019 Mar; 316(3):L487-L497. PubMed ID: 30604628
[TBL] [Abstract][Full Text] [Related]
30. Comparison of clinical courses and mortality of connective tissue disease-associated interstitial pneumonias and chronic fibrosing idiopathic interstitial pneumonias.
Yıldırım F; Türk M; Bitik B; Erbaş G; Köktürk N; Haznedaroğlu Ş; Türktaş H
Kaohsiung J Med Sci; 2019 Jun; 35(6):365-372. PubMed ID: 30913371
[TBL] [Abstract][Full Text] [Related]
31. Serum CA 15-3 is increased in pulmonary fibrosis.
Ricci A; Mariotta S; Bronzetti E; Bruno P; Vismara L; De Dominicis C; Laganà B; Paone G; Mura M; Rogliani P; Mastrangeldo M; Sciacchitano S; Saltini C
Sarcoidosis Vasc Diffuse Lung Dis; 2009 Jul; 26(1):54-63. PubMed ID: 19960789
[TBL] [Abstract][Full Text] [Related]
32. Potential action of IL-4 and IL-13 as fibrogenic factors on lung fibroblasts in vitro.
Saito A; Okazaki H; Sugawara I; Yamamoto K; Takizawa H
Int Arch Allergy Immunol; 2003 Oct; 132(2):168-76. PubMed ID: 14600429
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of the Diagnostic Efficacies of Serological Markers KL-6, SP-A, SP-D, CCL2, and CXCL13 in Idiopathic Interstitial Pneumonia.
Xue M; Guo Z; Cai C; Sun B; Wang H
Respiration; 2019; 98(6):534-545. PubMed ID: 31665737
[TBL] [Abstract][Full Text] [Related]
34. [The expressions and meanings of BMP-7 and TGF-β in idiopathic pulmonary fibrosis and idiopathic nonspecific interstitial pneumonia].
Gu P; Luo B; Yi X; Zhu H; Li S; Yu X; Han F; Zhang S; Zhu X; Rui W; Qiu W; Fan D
Zhonghua Jie He He Hu Xi Za Zhi; 2014 Sep; 37(9):664-70. PubMed ID: 25533688
[TBL] [Abstract][Full Text] [Related]
35. Idiopathic pulmonary fibrosis in small cell lung cancer as a predictive factor for poor clinical outcome and risk of its exacerbation.
Koyama N; Iwai Y; Nagai Y; Aoshiba K; Nakamura H
PLoS One; 2019; 14(8):e0221718. PubMed ID: 31442290
[TBL] [Abstract][Full Text] [Related]
36. Fibroblast-matrix interplay: Nintedanib and pirfenidone modulate the effect of IPF fibroblast-conditioned matrix on normal fibroblast phenotype.
Epstein Shochet G; Wollin L; Shitrit D
Respirology; 2018 Aug; 23(8):756-763. PubMed ID: 29532550
[TBL] [Abstract][Full Text] [Related]
37. Sirtuin 7 is decreased in pulmonary fibrosis and regulates the fibrotic phenotype of lung fibroblasts.
Wyman AE; Noor Z; Fishelevich R; Lockatell V; Shah NG; Todd NW; Atamas SP
Am J Physiol Lung Cell Mol Physiol; 2017 Jun; 312(6):L945-L958. PubMed ID: 28385812
[TBL] [Abstract][Full Text] [Related]
38. Exosome-Derived microRNA-22 Ameliorates Pulmonary Fibrosis by Regulating Fibroblast-to-Myofibroblast Differentiation in Vitro and in Vivo.
Kuse N; Kamio K; Azuma A; Matsuda K; Inomata M; Usuki J; Morinaga A; Tanaka T; Kashiwada T; Atsumi K; Hayashi H; Saito Y; Seike M; Gemma A
J Nippon Med Sch; 2020 Jul; 87(3):118-128. PubMed ID: 31776321
[TBL] [Abstract][Full Text] [Related]
39. Role of CD248 as a potential severity marker in idiopathic pulmonary fibrosis.
Bartis D; Crowley LE; D'Souza VK; Borthwick L; Fisher AJ; Croft AP; Pongrácz JE; Thompson R; Langman G; Buckley CD; Thickett DR
BMC Pulm Med; 2016 Apr; 16(1):51. PubMed ID: 27080864
[TBL] [Abstract][Full Text] [Related]
40. Innate immunity alterations in idiopathic interstitial pneumonias and rheumatoid arthritis-associated interstitial lung diseases.
Papanikolaou IC; Boki KA; Giamarellos-Bourboulis EJ; Kotsaki A; Kagouridis K; Karagiannidis N; Polychronopoulos VS
Immunol Lett; 2015 Feb; 163(2):179-86. PubMed ID: 25540922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
